The Biden administration had proposed late last year coverage of the popular medicines for obesity.
Its flawed income measure leads to the overpayment of welfare, including Medicaid, to recipients.
New investors Menlo Ventures, SignalFire back startup as insurance coverage for patient advocacy expands.
Photo: Free to Choose Network The Trump administration recently promised that it “will not cut Social Security, Medicare, or Medicaid benefits.” The determination not to reform retirement ...
Minutes after the U.S. stock market registered its worst week in more than five years, the Trump administration put out a ...
2don MSN
Medicare Advantage − the private option that costs taxpayers extra and requires prior approval − is the default for some ...
A Wall Street Journal reporting team reveals how they got access to a huge tranche of Medicare data and offer four reporting tips.
The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, ...
President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the government-funded Medicare program ...
Marko Elez has been assigned to the U.S. Department of Health and Human Services since March 5, per court filings.
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback